Peter Attia· MD
one of the ways that we treat Parkinson's is to actually give people l dopa which is a dopamine precursor why do we give them L Doopa and not dopamine because dopamine itself actually can't cross the blood brain barrier
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
one of the ways that we treat Parkinson's is to actually give people l dopa which is a dopamine precursor why do we give them L Doopa and not dopamine because dopamine itself actually can't cross the blood brain barrier
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.